505 filings
Page 7 of 26
8-K
2dry8a6
29 Mar 22
OpGen Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:16pm
8-K
mwjxv u62147v80h4l
3 Mar 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:37pm
8-K
19lwhm9bwmgmklb
10 Jan 22
OpGen Announces Preliminary Unaudited Revenue for Fiscal 2021 and Provides Business Update
4:32pm
8-K
n83yxdeopisk7
8 Dec 21
OpGen Announces Results of Special Meeting of Stockholders
4:40pm
8-K
tdlii1 zbq
30 Nov 21
OpGen Subsidiary Ares Genetics Announces Strategic Database Access Transaction
4:18pm
8-K
jsonp 65lq
12 Nov 21
OpGen Reports Third Quarter 2021 Financial Results and Provides Business Update
6:35am
DEFA14A
y4qmqcf
9 Nov 21
Additional proxy soliciting materials
4:50pm
DEFA14A
oouzntfgybk fau9dyl
4 Nov 21
Additional proxy soliciting materials
8:23am
8-K
432myyxdhi6dunyxn8y
4 Nov 21
OpGen Appoints Albert Weber as Chief Financial Officer
8:21am
DEFA14A
zgubdp67rm10s4p43
4 Nov 21
Additional proxy soliciting materials
7:31am
8-K
ty51pkdo6qgcqs1s06a
4 Nov 21
Regulation FD Disclosure
7:30am
DEFA14A
rg1vdj uccbkydm
29 Oct 21
Additional proxy soliciting materials
10:07am
DEFA14A
0w2rklvz
29 Oct 21
Additional proxy soliciting materials
10:05am
424B5
0tjlzqaeyhehn3
15 Oct 21
Prospectus supplement for primary offering
4:47pm
8-K
e7tqx3b 4oth
15 Oct 21
OpGen Announces $15 Million Registered Direct Offering
4:31pm